Personalizing Radiation Treatment Delivery in the Management of Breast Cancer
Long-term data establishes the efficacy of radiotherapy in the adjuvant management of breast cancer. New dose and fractionation schemas have evolved and are available, each with unique risks and rewards. Current efforts are ongoing to tailor radiotherapy to the unique biology of breast cancer. In th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2018/6729802 |
id |
doaj-ee765a08ba8745459fbdace64229f26e |
---|---|
record_format |
Article |
spelling |
doaj-ee765a08ba8745459fbdace64229f26e2020-11-24T21:39:02ZengHindawi LimitedInternational Journal of Breast Cancer2090-31702090-31892018-01-01201810.1155/2018/67298026729802Personalizing Radiation Treatment Delivery in the Management of Breast CancerKamran A. Ahmed0G. Daniel Grass1Amber G. Orman2Casey Liveringhouse3Michael E. Montejo4Hatem H. Soliman5Heather S. Han6Brian J. Czerniecki7Javier F. Torres-Roca8Roberto Diaz9Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USAUniversity of South Florida College of Medicine, Tampa, FL 33612, USADepartment of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USADepartment of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USALong-term data establishes the efficacy of radiotherapy in the adjuvant management of breast cancer. New dose and fractionation schemas have evolved and are available, each with unique risks and rewards. Current efforts are ongoing to tailor radiotherapy to the unique biology of breast cancer. In this review, we discuss our efforts to personalize radiotherapy dosing using genomic data and the implications for future clinical trials. We also explore immune mechanisms that may contribute to a tumor’s unique radiation sensitivity or resistance.http://dx.doi.org/10.1155/2018/6729802 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kamran A. Ahmed G. Daniel Grass Amber G. Orman Casey Liveringhouse Michael E. Montejo Hatem H. Soliman Heather S. Han Brian J. Czerniecki Javier F. Torres-Roca Roberto Diaz |
spellingShingle |
Kamran A. Ahmed G. Daniel Grass Amber G. Orman Casey Liveringhouse Michael E. Montejo Hatem H. Soliman Heather S. Han Brian J. Czerniecki Javier F. Torres-Roca Roberto Diaz Personalizing Radiation Treatment Delivery in the Management of Breast Cancer International Journal of Breast Cancer |
author_facet |
Kamran A. Ahmed G. Daniel Grass Amber G. Orman Casey Liveringhouse Michael E. Montejo Hatem H. Soliman Heather S. Han Brian J. Czerniecki Javier F. Torres-Roca Roberto Diaz |
author_sort |
Kamran A. Ahmed |
title |
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer |
title_short |
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer |
title_full |
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer |
title_fullStr |
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer |
title_full_unstemmed |
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer |
title_sort |
personalizing radiation treatment delivery in the management of breast cancer |
publisher |
Hindawi Limited |
series |
International Journal of Breast Cancer |
issn |
2090-3170 2090-3189 |
publishDate |
2018-01-01 |
description |
Long-term data establishes the efficacy of radiotherapy in the adjuvant management of breast cancer. New dose and fractionation schemas have evolved and are available, each with unique risks and rewards. Current efforts are ongoing to tailor radiotherapy to the unique biology of breast cancer. In this review, we discuss our efforts to personalize radiotherapy dosing using genomic data and the implications for future clinical trials. We also explore immune mechanisms that may contribute to a tumor’s unique radiation sensitivity or resistance. |
url |
http://dx.doi.org/10.1155/2018/6729802 |
work_keys_str_mv |
AT kamranaahmed personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT gdanielgrass personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT ambergorman personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT caseyliveringhouse personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT michaelemontejo personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT hatemhsoliman personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT heathershan personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT brianjczerniecki personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT javierftorresroca personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer AT robertodiaz personalizingradiationtreatmentdeliveryinthemanagementofbreastcancer |
_version_ |
1725932997989892096 |